Skip to main content

Table 1 Baseline demographics and disease characteristics (treated set)

From: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

 

Total

Patients, n (%)

101 (100)

  Male

69 (68.3)

  Female

32 (31.7)

Race, n (%)

 

  White

101 (100)

Age (years), mean ± SD

8.8 ± 1.7

  6–8 years, n (%)

37 (36.6)

  9–11 years, n (%)

64 (63.4)

Weight (kg), mean ± SD

34.2 ± 10.5

Height (cm), mean ± SD

138.9 ± 12.2

BMI (kg/m2), mean ± SD

17.4 ± 3.2

Smoking exposure, n (%)

 

  No exposure

95 (94.1)

  Exposure to household/second-hand smoking

6 (5.9)

Duration of asthma (years), mean ± SD

4.5 ± 2.3

  <1 year’s duration, n (%)

6 (5.9)

  1–< 3 years’ duration, n (%)

18 (17.8)

  ≥3 years’ duration, n (%)

77 (76.2)

  1. BMI, body mass index; SD, standard deviation.